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The lymphocyte transformation test (LTT) has been shown to be a reliable method of
demonstrating the antigen of delayed-type allergic responses. The test is based upon the
process of gradual enlargement, transformation into lymphoblasts, and mitotic activity of
small mature lymphocytes in the peripheral blood which occurs when they come into
contact with an antigen to which the organism has previously been sensitized (Pearman,
Lycette, and Fitzgerald, I963; Marshall and Roberts, I963; Daniels, Ritzmann, and
Levin, I968; Ling, I968). The mechanism of this blastic transformation appears to be
identical with that of lymphocyte activation observed in the course of homograft rejection.
Blastogenesis will not take place if no antigen has been added to the lymphocyte cultures,
or if the donor organism has not been previously sensitized to the antigen tested.
Phytohaemagglutinin (PHA) is known to stimulate aspecifically the blastic transformation
of lymphocytes cultured from healthy subjects (Hungerford, Donelly, Nowell, and Back,
I959; Nowell, I960), but this stimulation does not occur if the subject suffers from a
disease damaging the immune apparatus or is receiving immunosuppressive treatment
(Daniels and others, I968; Bozsoky, I969).
In this paper the effects of uveal pigment and PHA on lymphocyte cultures from patients
with sympathetic ophthalmitis (SO) or the Vogt-Koyanagi-Harada syndrome (VKHS)
are compared.
Methods
LYMPHOCYTE CULTURES
These were taken from two patients suffering from the VKHS and three with SO. Cultures from
five ophthalmologically healthy subjects served as controls. Diagnosis was based on the histories
and typical clinical signs as well as the histological findings.
ANTIGENS
Uveal pigment not containing soluble proteins prepared from bovine eyes according to the method
of Woods (I925) was used for specific stimulation. Phytohaemagglutinin M (o-oI U/ml.) manu-
factured by Difco was used for aspecific transformation.
CULTIVATION OF LYMPHOCYTES
Lymphocytes isolated from citrated venous blood by sedimentation were cultured in a 5-fold volume
of Parker igg solution (Simon, Dobozy, and Hunyadi, I969). The lymphocytes were not separated
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from the other leucocytes during the experiments. The stimulating compounds were added at the
start of cultivation, in o I ml. volume per culture. At least three 3-ml. cultures were secured from
each subject; the first was stimulated with appropriately diluted uveal pigment, the second with
PHA, and the third, used as control, with isotonic saline.
After cultivation for 4 days, 3p Ci H 3-thymidine was added in o * i ml. volume to each culture and
cultivation was continued for an additional period of 24 hours. On the fifth day, 5 per cent. tri-
chloracetic acid was added to the cultures to precipitate the macromolecules, and acid-soluble
thymidine was removed by washing three times in trichloracetic acid. The scintillation counts of
the DNA-containing sediment were established by means of a Tri-Carb apparatus (Packard).
The rate of stimulation was estimated from the increment of H 3-thymidine incorporation, a
manifestation of the increased synthesis of DNA during blast transformation. The extent of blast
transformation was assessed from the ratio of scintillation-counts in stimulated and non-stimulated
cultures; the LTT was considered to be positive if this index was higher than I*5.
Results
The concentration ofuveal pigment eliciting the highest degree of blast transformation was
determined first. Lymphocyte cultures from one patient with SO and from another with
the VHKS were stimulated with different concentrations of the antigen. The incorpor-
ation of H3-thymidine was highest at a final concentration of 2 jg/ml. uveal pigment.
Higher and lower concentrations resulted in lower transformation indices (Table I).
Uveal pigment was used at 2 tg/ml. level in all subsequent experiments.
Table U Blast transformation stimulating
effects ofuveal pigment andPHA in lymphocyte
Table I Determination ofoptimal stimulating cultures obtained from patients and healthy
dose of uveal pigment controls
Quotient ofscintillation counts
Concentration of (index) in cultures stimulated and
uveal pigment not stimulated by uveal pigment(pg./ml.)
VKHS SO
200-0 I-4 12
20-0 1 *9 211
2-0 2-3 2-6
0-2 2-0 I-8
0-02 I.3 1.4
Patient no. Diagnosis Uveal pigment PHA
I VKHS I*7 9*2
2 2-9 5.3
3 So 2-I 6-7
4 I-6 8-8
5 2-4 5vO
6 Control I*I 8-9
7 o-8 7'3
8 I-0 3'9
9 1-2 I2-5
10 O°9 5 6
The figures represent quotients (indices) of scintil-
lation counts in cultures stimulated and non-
stimulated
The specific transformation elicited by uveal pigment yielded more than I 5-fold
increase of H3-thymidine incorporation into the lymphocyte cultures of all patients
suffering from SO or the VKHS. The same antigen failed to stimulate the lymphocyte
cultures of the ophthalmologically healthy subjects. Blast transformation evoked by
PHA was of much greater degree than that due to the specific antigen, but was of about
the same magnitude in cultures from patients and healthy subjects (Table II).
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Discussion
Elschnig (i9io) and Woods and Little (I933) were the first to postulate the antigenic role
of pigment in the pathogenesis of SO. This idea was supported by Friedenwald (I934),
who compared the tissue-reaction after the intracutaneous administration of uveal pigment
to the features of SO (Friedenwald, I934); this is now interpreted as a delayed-type
allergic response to the pigment. McPherson and Woods (1948) obtained identical
results in the VKHS and SO with the uveal pigment skin-test. Kahan and Sztanojevits
(I964) observed a correlation between the results of the skin-test and the activity of the
above diseases. Uveal pigment agglutinating antibodies were demonstrated in the sera of
patients suffering from the VKHS or SO if the combining antibodies were completed by
Coombs-serum (Kahan, Sztanojevits, Szabados, Vass, and Szabo, I964).
In the present experiments, the lymphocyte cultures of all patients with SO or the
VKHS could be stimulated by uveal pigment, but the pigment consistently failed to
enhance the incorporation of H3-thymidine into cultures from healthy subjects.
These findings suggest that the uveal pigment has a specific transforming action upon the
lymphocytes in these diseases. As most authors agree upon the reliability of the LTT in
confirming delayed hypersensitivity, it is concluded that autoaggressive cell-bound
responses to the pigment may play a role in the pathogenesis of both SO and the VKHS.
Summary
Lymphocyte cultures from two patients with histologically confirmed Vogt-Koyanagi-
Harada syndrome and from three patients with sympathetic ophthalmitis were stimulated
with bovine uveal pigment. The best antigen concentration was 2 pg/ml., which increased
the blast transformation i *6 to 2.9 times, as assessed by the incorporation of H3-thymidine.
The uveal pigment failed to stimulate the lymphocyte cultures from healthy subjects.
The specific transforming action of uveal pigment indicates that these diseases are of a
pigment autoaggressive delayed allergic nature.
References
BOZS6KY, S. (I969) Orvoskipzes, 44, 49
DANIELS, J. c., RITZMANN, S. E., and LEVIN, w. c. (I968) Texas Rep. Biol. Med., 26, 5
ELSCHNIG, A. (1910) v. Graefes Arch. Ophthal., 75, 459
FRIEDENWALD, J. s. (I934) Amer. J. Ophthal., 17, Ioo8
HUNGERFORD, D. A., DONELLY, A. J., NOWELL, P. c., and BECK. S. (1959) Amer. J. hum. Genet., Ii,
no. 3, 2I5
KAHAN, A., and SZANOJEVITS, A. (I964) Szemeszet, IOI, I99
9 , SZABADOS, T., VASS, Z., and SZAB6, M. (I964) v. Graefes Arch. Ophthal., 167, 246
LING, N. R. (I968) "Lymphocyte Stimulation". North-Holland, Amsterdam
MARSHALL, W. H., and ROBERTS, K. B. (I963) Lancet, I, 773
McPHERSON, S. D., and WOODS, A. C. (1948) Amer. J. Ophthal., 31, 35
NOWELL, P. c. (I960) Cancer Res., 20, 462
PEARMAIN, G. LYCETTE, R. R., and FITZGERALD, P. H. (I963) Lancet, I, 637
SIMON, N., DOBOZY, A.,and HUNYADI, J. (i969) Arch. klin. exp. Derm., 236, I
WOODS, A. C. (1925) Trans. ophthal. Soc. U.K., 45, 208
and LITTLE, M. F. (I933) Arch. Ophlhal., 9, 200
852
